Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Silicon Laboratories reported Q3 2026 revenue of $251 million, a 22% year-over-year increase driven by record medical revenue and broad-based growth in Industrial & Commercial and Home & Life segments. GAAP diluted EPS improved to $0.26 from a loss in the prior year, while non-GAAP EPS rose 228% to $1.05. The company suspended forward-looking guidance due to its pending acquisition by Texas Instruments.
Term
Q3 2026
“We delivered strong third-quarter results, with revenue up 10% sequentially, underpinned by broad-based growth across many end applications and another record quarter for medical revenue as known customer ramps continued. Earnings significantly outpaced revenue growth, a result of strong operational execution by the team. Looking ahead, our current backlog and design-win ramps position us for continued revenue growth and meaningful earnings expansion.”
Matt Johnson, President and Chief Executive Officer
Rigetti Computing reported total assets of $623.9 million as of September 30, 2026, a decrease from $666.6 million at year-end 2025. The company maintains a strong liquidity position with $45.8 million in cash and $337.5 million in short-term investments, while common stock outstanding reached 342,783,018 shares as of November 6, 2026.
Orion180 Insurance Group Inc. reported significant growth for the nine months ended September 30, 2026, with total revenues increasing to $134.0 million from $84.5 million in the prior year. The company successfully completed its initial public offering during the third quarter, raising $224.4 million in net proceeds, which contributed to a substantial increase in total assets to $936.9 million.
Grocery Outlet reported a net loss of $161.4 million for the 39 weeks ended October 3, 2026, primarily driven by a $158.0 million goodwill impairment charge and $20.1 million in restructuring charges. Despite these non-cash and one-time costs, net sales for the period grew slightly to $3.54 billion compared to $3.47 billion in the prior year period.
Gevo reported record third quarter 2026 financial results, driven by its carbon business and the sale of Canadian Clean Fuel Regulation (CFR) credits. The company achieved net income of $23 million and record revenue of $83 million, significantly improving its cash position to $68 million.
Term
Q3 2026
“The quarter marked our strongest financial performance to date, with record revenue, net income, Adjusted EBITDA and cash flow from operations. We said we would build a carbon business that stands on its own in 2026. These results show it’s working.”
Paul Bloom, Chief Executive Officer
“Gevo has a powerful growth platform built on low-carbon fuels, carbon and maximizing incentives. We have focused development around our existing operations, improving margins and near-term cash flow, with a portfolio of growth projects we believe will create substantial shareholder value.”
Anterix Inc. reported spectrum revenue of $3.9 million for the six months ended September 30, 2026, up from $3.0 million in the prior year. The company maintained a strong liquidity position with $107.5 million in cash and cash equivalents, while continuing to execute its strategy of commercializing 900 MHz spectrum assets for utility and critical infrastructure customers.
Janus International Group reported a net loss of $13.3 million for the third quarter of 2026, compared to a net income of $15.2 million in the prior year period, primarily driven by an $18.3 million impairment charge and higher cost of revenues. Total revenues for the quarter decreased slightly to $213.1 million from $219.3 million, while the company continued its share repurchase program, increasing treasury stock to $145.6 million.
QT Imaging reported Q3 2026 revenue of $7.3 million, a 75% year-over-year increase, driven by the sale of 15 Breast Acoustic CT scanners. The company achieved a major regulatory milestone with CMS establishing a Medicare hospital outpatient payment pathway for diagnostic QTscan examinations effective January 1, 2027. Full-year 2026 revenue guidance was adjusted to approximately $34 million due to international shipment delays caused by conflict in the Middle East.
Term
Q3 2026
“Our third-quarter results demonstrate the continued growth of QT Imaging, with revenue increasing 75% year over year and reaching $21.3 million for the first nine months of 2026, approximately double the prior-year period.”
Dr. Raluca Dinu, Chief Executive Officer of QT Imaging
“A major milestone is the recent CMS decision establishing separate Medicare hospital outpatient payment for medically necessary diagnostic QTscan examinations, effective January 1, 2027. Together with our dedicated billing code, effective October 1, this decision removes a significant reimbursement uncertainty and strengthens our ability to expand into U.S. hospitals and health systems.”
Dr. Raluca Dinu, Chief Executive Officer of QT Imaging
INOVIO reported Q3 2026 financial results and highlighted the landmark FDA accelerated approval of VOCERYQ, the first-ever approved DNA medicine, for the treatment of Recurrent Respiratory Papillomatosis (RRP). The company recently completed a public offering raising $80.5 million in net proceeds to support the commercial launch of VOCERYQ, which is expected to be available for order in early 2027.
“We are delighted with the recent approval of VOCERYQ, which FDA described as a groundbreaking therapy that fights RRP at its source, not only its symptoms. INOVIO is now a commercial stage company with a primary goal to establish VOCERYQ as the preferred first-line immunotherapy for RRP patients.”
Dr. Jacqueline Shea, INOVIO’s President and Chief Executive Officer
“Our recently completed public offering provides additional financial resources to support a successful launch. Furthermore, this approval validates our DNA medicine platform and we are actively seeking partnerships to accelerate the development of other exciting candidates within our pipeline”
Dr. Jacqueline Shea, INOVIO’s President and Chief Executive Officer
Beachbody (BODi) reported its fifth consecutive quarter of net income and operating income for Q3 2026, with net income and Adjusted EBITDA exceeding the high end of guidance. While total revenue declined to $45.2 million from $59.9 million year-over-year, the company maintained a 70.7% gross margin and achieved its twelfth consecutive quarter of positive Adjusted EBITDA.
Term
Q3 2026
“Net income and adjusted EBITDA exceeded the high end of our guidance and revenue met expectations as we continue to transform our business model. As the proactive wellness company delivering nutrition, supplements and proven fitness programs that help people take control of their health, we are executing on our omni-channel strategy to place our iconic brands wherever shoppers are.”
Carl Daikeler, co-founder and BODi’s Chief Executive Officer
“Our third quarter results mark our twelfth consecutive quarter of positive Adjusted EBITDA and our fifth consecutive quarter of double-digit Adjusted EBITDA margins, reflecting the operating discipline we have built into this company.”
Braveheart Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing its lead candidate BHB-1893 for hypertrophic cardiomyopathy (HCM). The company reports a limited operating history with significant losses and expects to require substantial additional funding to support its ongoing clinical trials, including LIONHEART-HCM and TRUEHEART-HCM.
Airgain reported Q3 2026 revenue of $15.3 million, up 12% sequentially and 9% year-over-year, driven by strong momentum in its enterprise IoT business. The company achieved a non-GAAP net income of $0.5 million and secured new design wins for AI data center infrastructure, though it continues to navigate near-term supply constraints.
Term
Q3 2026
“Airgain delivered another strong quarter of progress, with revenue increasing 12% quarter-over-quarter and 9% year-over-year, driven by continued momentum in our enterprise IoT business.”
Jacob Suen, President and CEO of Airgain
“Our results reflect growing demand across established industrial applications, along with new opportunities in areas such as AI data center infrastructure.”
Dermata Therapeutics reported financial results for the third quarter of 2026, highlighting its transition to a revenue-generating company following the August 2025 launch of Tome Foundational Treatment. The company reported its first product revenue and noted that approximately 30% of orders were generated via subscriptions.
Term
Q3 2026
“The third quarter represents a transformational time for Dermata as we completed our transition from a development-stage pharmaceutical company to a revenue-generating commercial skincare business.”
Gerry Proehl, Dermata’s Chairman, President, and Chief Executive Officer
“With the launch of Tome Foundational Treatment on August 25, 2026, we began generating our first product revenue, marking an important step in executing our strategy to build a differentiated skincare brand around BioneedleTM, our hero ingredient, consisting of 100% freshwater sponge, which we wild harvest and minimally process into a fine, purified powder.”
Gerry Proehl, Dermata’s Chairman, President, and Chief Executive Officer
Mobile Infrastructure Corporation reported its third quarter 2026 financial results, highlighted by a 12.8% increase in same-location revenue and an 18.4% increase in same-location NOI. The company achieved record RevPAS growth of 16% driven by a 13 percentage point improvement in utilization across its parking portfolio.
Term
Q3 2026
“We are pleased with our third quarter results, marking Mobile’s strongest operating quarter of 2026, building strong momentum heading into 2027, and achieving our highest utilization and RevPAS to date.”
Stephanie Hogue, Chief Executive Officer
“At the start of the year, we discussed our strategy of building utilization first, establishing a larger and more durable base of recurring and transient demand, and following this with improved, sustainable pricing as utilization improves. Our results in the third quarter evidence strong execution as our strategy translates into earnings improvement.”
QumulusAI reported third quarter 2026 revenue of $14.8 million, a 376% increase year-over-year, driven by its neocloud compute infrastructure. The company achieved its first positive Adjusted EBITDA of $3.7 million while cumulative signed customer contract value surpassed $500 million following new agreements for NVIDIA Blackwell GPU clusters.
Term
Q3 2026
“Revenue doubled again this quarter, and remaining performance obligations grew to $515.0 million from $173.1 million at the end of the second quarter. That’s the model doing its job: we sell the capacity before we energize it, we deploy into pockets of existing power, and we bring it online in months, not years.”
Fold Holdings reported Q3 2026 financial results, highlighting a 270% increase in custody and trading revenue and the launch of Fold Reserve and Lead Bank accounts. The company reduced operating expenses by 21% year-over-year and is transitioning its business model from transaction-based to balance-based economics.
Term
Q3 2026
“We believe Q3 was an inflection point for Fold. Over the last few months we’ve evolved from strictly a transaction-based business to one that also monetizes customer balances, broadened our focus from bitcoin earners to every American who earns rewards, strengthened our balance sheet, maintained a focus on operational efficiency, and opened new distribution channels that take our products to audiences we’ve never reached before.”
Will Reeves, Chairman and CEO
“We are reshaping Fold from a business built on gathering customers into one built on gathering assets. A transaction pays us once. A customer balance earns for us every month it stays on the platform, and it ties that customer more closely to everything else we offer.”
TransDigm Group INC continues to focus on a high-leverage capital structure and proprietary aerospace components, with its top ten customers accounting for 45% of net sales in fiscal 2026. The company operates through three segments—Power & Control, Airframe, and Non-aviation—serving commercial aftermarket, OEM, and defense markets.
Dakota Gold Corp. reported a net loss of $25.23 million for the nine months ended September 30, 2026, compared to $20.70 million in the prior year period. The company significantly strengthened its liquidity position, ending the period with $92.15 million in cash and cash equivalents following successful common stock offerings and warrant exercises.
The Grayscale Hyperliquid Staking ETF commenced operations on June 3, 2026, and held 2,219,189.85 HYPE tokens valued at $196.9 million as of September 30, 2026. The Trust recognizes staking rewards as revenue on a net basis under ASC 606 and distributed $368,736 in cash to shareholders from these rewards during the quarter.
For the quarter ended September 30, 2026, Gladstone Land reported total operating revenues of $31.5 million and net income attributable to common stockholders of $6.1 million, a significant improvement from the prior year's quarterly loss. However, for the nine-month period, the company recorded a net loss of $17.4 million, primarily driven by higher impairment charges and property operating expenses.
Ambow Education Holding Ltd. reported total net revenues of $6.85 million for the nine months ended September 30, 2026, a slight increase from $6.48 million in the prior year. The company experienced a net loss of $0.50 million for the period compared to a net income of $1.27 million in 2025, primarily driven by higher operating expenses and the absence of a prior-year gain on lease settlement.
Anteris Technologies Global Corp. reported a net loss of $78.5 million for the nine months ended September 30, 2026, driven by significant research and development expenses of $62.2 million. The company's financial position improved substantially during the period, with cash and cash equivalents increasing to $232.8 million following the issuance of common stock, resulting in a total stockholders' equity of $226.8 million.
Co-Diagnostics, Inc. reported a net loss of $21.7 million for the nine months ended September 30, 2026, compared to a $21.2 million loss in the prior year. Total revenue increased to $594,966 from $358,567, while cash and cash equivalents significantly decreased to $714,803 from $11.9 million at the start of the year.
CoreWeave reported record third quarter 2026 revenue of $3.66 billion, a significant increase from $1.37 billion in the prior year, driven by massive demand for AI infrastructure. Despite the revenue growth, the company reported a net loss of $709 million due to high interest expenses and rapid scaling costs. Management highlighted a revenue backlog of $132.5 billion and plans to receive $9 billion in customer prepayments over the next three months.
Term
Q3 2026
“This was a breakout quarter for CoreWeave, with revenue increasing by more than $1 billion sequentially and adjusted operating margins reaching double digits a quarter ahead of plan.”
Michael Intrator, co-founder, chairman and chief executive officer of CoreWeave
“Our growth is supported by multiple sources of funding, including financing backed by customer contracts, operating cash flow, and approximately $9 billion in customer prepayments and deposits expected in the next three months alone.”
Michael Intrator, co-founder, chairman and chief executive officer of CoreWeave
Fortitude Gold Corp reported a net loss of $4.4 million for the nine months ended September 30, 2026, compared to a net income of $2.3 million in the prior year, primarily driven by a significant increase in exploration and reclamation expenses. Despite the loss, the company strengthened its cash position to $8.5 million through a $17.2 million stock issuance and $5.5 million in funding from noncontrolling interests.
Freenome reported its first quarterly results as a public company, highlighted by $183.5 million in revenue following the FDA approval of its SimpleScreen CRC blood test. The company achieved GAAP net income of $60.1 million, a significant turnaround from a net loss in the prior year, and ended the quarter with $430 million in cash and marketable securities.
Term
Q3 2026
“Freenome made meaningful progress in its first quarter as a public company, executing on our strategic partnerships and strengthening our operating foundation.”
ACCESS Newswire Inc. reported a net loss of $1.17 million for the nine months ended September 30, 2026, compared to a net income of $4.87 million in the prior year period, which was bolstered by discontinued operations. Total revenues decreased slightly to $16.46 million from $16.82 million year-over-year, while the company maintained a cash balance of approximately $2.99 million.
Orion180 Insurance Group reported third quarter 2026 financial results, highlighted by a 32% increase in net income to $11.5 million and a 60% growth in managed premiums written to $204 million. The quarter marked the company's first as a public entity following its IPO in September 2026, with managed premiums in-force reaching $678 million.
Term
Q3 2026
“We delivered an excellent quarter across our key metrics, rapidly growing our managed premiums while significantly increasing our profitability on a year-over-year basis. In addition, we achieved a major milestone in our Company’s history by successfully completing our initial public offering. We believe our results reflect the strength, differentiation and scalability of the business model we have built over the past eight years.”
Kenneth Gregg, Chief Executive Officer of Orion180
“We are well-positioned to produce durable growth on both our top and bottom lines, which is driven by our attractive suite of homeowners solutions - including our flagship FLEX product - as well as our proprietary end-to-end MY180 tech platform, which allows us to seamlessly combine best-in-class underwriting, claims management, and real-time analytic capabilities.”
Kenneth Gregg, Chief Executive Officer of Orion180
Lumexa Imaging reported Q3 2026 financial results with revenue growing 5% to $272.0 million and net income of $7.2 million. The company reiterated its full-year revenue guidance while raising its Adjusted EPS outlook to $0.86–$0.90 due to a lower effective tax rate.
Term
Q3 2026
“In Q3, we advanced our business in several meaningful ways while executing against our strategy. Advanced modalities reached a record high as a percent of our volumes, and our newer de novo cohorts continue to ramp on plan. We are actively opening three new de novo centers and are on pace to achieve our goal for 8–10 new center openings this year.”
Caitlin Zulla, Chief Executive Officer of Lumexa Imaging
“We are leading a transformation in healthcare - delivering high-quality imaging in more convenient settings, more quickly and at meaningfully lower cost through our wholly owned centers and alongside health system partners, improving clinical and financial outcomes.”
Caitlin Zulla, Chief Executive Officer of Lumexa Imaging
Velo3D reported Q3 2026 revenue of $20.5 million, a 50% year-over-year increase, driven by strong demand in aerospace and defense sectors. The company reported a GAAP net loss of $16.7 million as it invested in scaling its new Livermore Production Campus, Forge 1, which is expected to serve as its primary manufacturing center.
Term
Q3 2026
“We delivered solid third quarter results, with revenue increasing approximately 50% year-over-year to $20.5 million and new bookings reaching $28.9 million, exceeding revenue for the quarter. These results reflect continued customer demand for our metal additive manufacturing technology and the progress we are making in executing our growth strategy.”
Arun Jeldi, Chief Executive Officer of Velo3D
“Looking ahead, Forge 1 is central to Velo3D’s next phase of growth and is expected to significantly expand our production capacity as it becomes fully operational, enabling us to pursue larger production programs and capture opportunities across aerospace, defense, space and energy.”